Advertisement
Advertisement

ONC

ONC logo

BeOne Medicines Ltd. - ADR

311.95
USD
Sponsored
-1.47
-0.47%
Apr 10, 11:13 UTC -4
Open

BeOne Medicines Ltd. - ADR Profile

About

BeOne Medicines is an oncology company which involved in discovering and developing treatments to cancer patients. BeOne Medicines, formerly known as BeiGene Ltd., is based in SAN CARLOS, Calif.

Info & Links

CEO

John V. Oyler

Headquarters

C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR
BASEL, V8 4051, SWITZERLAND

Sector

Medical

Auditor

Ernst & Young LLP

Share holders

31,846

Employees

12,000

BeOne Medicines Ltd. - ADR Statistics

Valuation Measures

Market Capitalization2

34.63B

Enterprise Value

31.10B

Enterprise Value/EBITDA(ttm)

52.81

Price to Earnings Ratio(ttm)

83.70

Price to Sales(ttm)

6.41

Price to Book(mrq)

7.85

Price to Cash(ytd)

79.88

Profitability

Gross Margin(ttm)

87.32%

Operating Margin(ttm)

7.89%

Profit Margin(ttm)

5.14%

Return on Equity(ttm)

10.70%

Return on Invested Capital(ttm)

6.62%

Return on Assets(ttm)

6.03%

Income Statement

Revenue(ttm)

5.34B

Revenue Per Share(ttm)

48.16

Gross Profit(ttm)

4.67B

EBITDA(ttm)3

588.82M

Net Income Available to Common(ttm)

286.93M

Diluted EPS(ttm)

2.52

Share Statistics

Beta (5Y Monthly)

0.53

52-Week Change

51.20%

S&P 500 52-Week Change

29.78%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

110.94M

Dividend Yield

0.00%

Float4

102.46M

% Held by Insiders

6.62%

% Held by Institutions

48.55%

Balance Sheet

Total Cash(mrq)

4.55B

Total Cash Per Share(mrq)

40.99

Total Debt(mrq)

1.02B

Total Debt/Equity(mrq)

23.37%

Current Ratio(mrq)

3.41%

Quick Ratio(mrq)

3.08%

Book Value Per Share(mrq)

39.34

Cash Flow

Operating Cash Flow Per Share(ytd)

9.94

Free Cash Flow(ytd)

941.74M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement